SCHEMBL11029945

SCHEMBL11029945

CCCCCC1(C(=O)O)CC1CN

nearest known ligand 0.50

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 7/20 0.37
SLC6A4 P31645 6/20 0.37
CPB2 Q96IY4 1/20 0.34
SLC6A3 Q01959 4/20 0.33
CYP2D6 P10635 1/20 0.33
HTR2C P28335 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPK1 P28482 1/20 0.33
ALOX15 P16050 1/20 0.32
AKR1B1 P15121 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1908101 0.86 SLC6A2 (0.35) SLC6A2SLC6A4SLC6A3CYP2D6HTR2C
SCHEMBL2053235 0.78 AKR1B1 (0.37) ALOX15AKR1B1
SCHEMBL2049103 0.77 GPR84 (0.39) ALOX15
SCHEMBL4259041 0.77 GPR84 (0.39) ALOX15
SCHEMBL10937554 0.77 GPR84 (0.39) ALOX15
SCHEMBL5899762 0.74 ARG1 (0.34) SLC6A2SLC6A4
SCHEMBL11214435 0.71 ALOX5 (0.40) AKR1B1
SCHEMBL4253394 0.71 AKR1B1 (0.31) KDM4EAKR1B1
SCHEMBL5899581 0.69 GRM2 (0.33)
SCHEMBL14714718 0.69 TERT (0.49) SLC6A2ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0068998-B1 (Z)-1-ARYL-2-AMINOMETHYL-CYCLOPROPANE-CARBOXYLATES, THEIR PREPARATION AND THEIR USE AS MEDICINES IN THE TREATMENT OF VARIOUS DISORDERS PIERRE FABRE S.A. (FR) 1985-08-28 EP claimed
EP-0068998-B1 (Z)-1-ARYL-2-AMINOMETHYL-CYCLOPROPANE-CARBOXYLATES, THEIR PREPARATION AND THEIR USE AS MEDICINES IN THE TREATMENT OF VARIOUS DISORDERS PIERRE FABRE S.A. (FR) 1985-08-28 EP disclosed
EP-0068998-A1 (Z)-1-aryl-2-aminomethyl-cyclopropane-carboxylates, their preparation and their use as medicines in the treatment of various disorders PIERRE FABRE S.A. (FR) 1983-01-05 EP disclosed